Yield Lab Europe

Yield Lab Europe

Yield Lab Europe was co-founded by Paul Finnerty and Brian Clevinger, with David Bowles serving as Managing Partner from its Dublin headquarters. The firm targets early-stage startups across the European region that are redesigning agriculture and food systems — a mandate stretching from genetic improvements in crops to novel farm-level sensors and alternative protein production. The team is built on the premise that agri-food-tech companies, particularly those dealing in hardware, require a fundamentally different support structure than enterprise software. The firm’s stated goal is to back companies that enhance agricultural sustainability and productivity, with capital deployed from seed to early-stage growth rounds. The firm’s portfolio is anchored in four thematic areas: on-farm productivity through precision management and data analytics; crop and animal genetic improvement; sustainable energy and material production from agricultural by-products; and novel farming systems. Confirmed portfolio companies include insect-pest monitoring specialist Spotta, nanobubble irrigation technology from Kapsera, methane-reducing livestock feed additive producer Oligofeed, and green ammonia fertilizer developer N2 Applied. The firm has also led rounds in insecticide-alternative developer Solasta Bio and weed-management hardware startup RootWave. Its approach frequently pairs equity investment with hands-on sector expertise, introducing portfolio companies to manufacturing partners and advisors within its network. Yield Lab Europe’s investment team is spread across two investment directors, a venture partner, and a general partner roster that includes both co-founders and Gentiane Gorlier. While total assets under management are not publicly disclosed, the firm’s capacity is demonstrated by its ability to lead rounds and maintain a portfolio that extends from Ireland and the UK to France and the Netherlands. Adjacent structures or vehicles are not separately disclosed; the operation appears consolidated under the Yield Lab Europe umbrella. In January 2025, the firm promoted Emilie Abrams to Investment Associate, signaling continued team development as deal flow expands. The firm’s structural distinction is its refusal to operate as a capital-only investor. For the hardware-intensive, long-science-cycle companies it backs, Yield Lab Europe functions as an extension of the founding team’s commercial arm, brokering relationships with manufacturers and supply-chain partners that a typical venture investor would leave to portfolio support. This integration of investment capital with operational matchmaking represents a genuine architectural choice — one designed to compress the timeline from laboratory proof-of-concept to first commercial shipment in an asset class where that gap often kills companies.